Abstract
This invention relates to new 1,3-dihydro-6-methyl-7-hydroxy-furo-(3,4-c)-pyridine derivatives of the general formula wherein A< represents a group of the formula -(CH2)n-, n being an integer of from 1 to 5, or a homocyclic or heterocyclic group, and R represents a hydrogen, chlorine or fluorine atom, a trifluoromethyl group, an alkyl group having from 1 to 5 carbon atoms, an alkoxy group having from 1 to 5 carbon atoms, a alkylthio group having from 1 to 5 carbon atoms, a dialkylaminoalkoxy group in which the alkyl groups each have from 1 to 5 carbon atoms and the alkoxy group has from 1 to 5 carbon atoms or a N-pyrolidinyl-alkoxy group in which the alkoxy group has from 1 to 5 carbon atoms to a process for the preparation of the same by refluxing alpha 4, 3-o-isopropylidene-pyridoxal with a compound of the general formula X-A-R, wherein X represents a bromine or iodine atom, in the presence of magnesium in diethyl ether, and acidifying the resultant corresponding secondary alcohol alpha 4, 3-o-isopropylidene- alpha -hydroxy-5-substituted-pyridoxine to break the isopropylidene ring and promote a 3,4 cyclization; and to therapeutical compositions of matter comprising as an essential ingredient therein an effective amount of one of these compounds.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.